IGFBP3 and type 1 diabetes mellitus: Given the altered IGFBP3 levels observed in diabetic patients, we interrogated TMEM219 expression in laser-captured islets through RNA sequencing and confirmed it in healthy subjects, patients with T1D, with T2D or at risk for T1D, without any difference among groups (Fig. 2k).